Etavopivat Tablets Low dose clinical trials

A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

This study is testing a new tablet medicine called etavopivat for people aged 12 to 65 with sickle cell disease. It aims to see if the medicine can improve a patient's red blood cells and reduce painful sickle cell crises. Half the group will receive the new treatment, the other a placebo.